Ionis wins FDA nod for triglyceride-lowering rare disease drug

Nature Biotechnology, Published online: 17 January 2src25; doi:1src.1src38/s41587-src24-src2546-zIonis wins FDA nod for triglyceride-lowering rare disease drug…

Nature Biotechnology, Published online: 17 January 2src25; doi:1src.1src38/s41587-src24-src2546-zIonis wins FDA nod for triglyceride-lowering rare disease drug…
Read More

About Author

Qiana Paris

See author's posts

Ionis wins FDA nod for triglyceride-lowering rare disease drug

About Author

Qiana Paris

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

Does Taking ‘The Pill’ Reduce Ovarian Cancer Risk?

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

FDA Updates ‘Healthy’ Claim for Foods — but Use Is Voluntary

How Cell Therapies Help Fight Solid Tumors

AI Catches Missing MRI Lesions

FDA Approves Second Generic Daily GLP-1 Drug for T2D

Psoriasis Affects an Estimated 3% of US Adults

Novo’s Weight Loss Drugs Removed from FDA Shortage List

‘Active recovery’ after exercise is supposed to improve performance—but does it really work?

The Surprising Source of Next-Gen Antibiotics: Oyster Blood

New GLP-1 Data Reinforce CV Benefit

Tool Predicts Whether One Bruise in Pediatric ED Signals Abuse

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories